BioWin Days 2025

23–24 Sept 2025 | Namur, Belgium

HomeAgendaPartnering

MRM Health

Other

www.mrmhealth.comGhent, Belgium
18 profile visits

About

MRM Health is a Belgian clinical-stage biotech developing innovative therapeutics for inflammatory, CNS and metabolic diseases. Our most advanced program MH002 is in preparation for pivotal clinical development in Ulcerative Colitis, upon obtaining positive clinical results in a phase 1/2 clinical trial, and is being evaluated in the orphan disease indication Pouchitis. MRM Health leverages on its disruptive CORAL® technology platform to design disease-focused microbiome-based biotherapeutics, based on combinations of 5 to 10 live gut bacteria, and manufacture these in a single standardized and scalable process. In addition to our program in Inflammatory Bowel Diseases, we additionally have ongoing preclinical programs in Parkinson’s Disease and Spondyloarthritis and partnered programs with IFF in Type 2 Diabetes and NAFLD.

Application domain

Biopharma

Therapeutic area

Disease of the musculoskeletal systemEndocrinologyGastrointestinal

Core Business

R&D

Representatives

Sam Possemiers

CEO

MRM Health